RNA Splicing Events in Circulation Distinguish Individuals With and Without New-onset Type 1 Diabetes

被引:1
|
作者
Webb-Robertson, Bobbie-Jo M. [1 ]
Wu, Wenting [2 ]
Flores, Javier E. [1 ]
Bramer, Lisa M. [1 ]
Syed, Farooq [2 ]
Tersey, Sarah A. [3 ,4 ]
May, Sarah C. [3 ,4 ]
Sims, Emily K. [2 ]
Evans-Molina, Carmella [2 ,5 ]
Mirmira, Raghavendra G. [3 ,4 ]
机构
[1] Pacific Northwest Natl Lab, Biol Sci Div, Richland, WA 99354 USA
[2] Indiana Univ Sch Med, Ctr Diabet & Metab Dis, Indianapolis, IN 46202 USA
[3] Univ Chicago, Diabet Res & Training Ctr, Chicago, IL 60637 USA
[4] Univ Chicago, Dept Med, Chicago, IL 60637 USA
[5] Roudebush Vet Affairs Med Ctr, Indianapolis, IN 46202 USA
基金
美国国家卫生研究院;
关键词
type; 1; diabetes; machine learning; alternative RNA splicing; biomarkers; RECEPTOR;
D O I
10.1210/clinem/dgae622
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Alterations in RNA splicing may influence protein isoform diversity that contributes to or reflects the pathophysiology of certain diseases. Whereas specific RNA splicing events in pancreatic islets have been investigated in models of inflammation in vitro, how RNA splicing in the circulation correlates with or is reflective of type 1 diabetes (T1D) disease pathophysiology in humans remains unexplored.Objective To use machine learning to investigate if alternative RNA splicing events differ between individuals with and without new-onset T1D and to determine if these splicing events provide insight into T1D pathophysiology.Methods RNA deep sequencing was performed on whole blood samples from 2 independent cohorts: a training cohort consisting of 12 individuals with new-onset T1D and 12 age- and sex-matched nondiabetic controls and a validation cohort of the same size and demographics. Machine learning analysis was used to identify specific isoforms that could distinguish individuals with T1D from controls.Results Distinct patterns of RNA splicing differentiated participants with T1D from unaffected controls. Notably, certain splicing events, particularly involving retained introns, showed significant association with T1D. Machine learning analysis using these splicing events as features from the training cohort demonstrated high accuracy in distinguishing between T1D subjects and controls in the validation cohort. Gene Ontology pathway enrichment analysis of the retained intron category showed evidence for a systemic viral response in T1D subjects.Conclusion Alternative RNA splicing events in whole blood are significantly enriched in individuals with new-onset T1D and can effectively distinguish these individuals from unaffected controls. Our findings also suggest that RNA splicing profiles offer the potential to provide insights into disease pathogenesis.
引用
收藏
页码:1148 / 1157
页数:10
相关论文
共 50 条
  • [1] Ergocalciferol in New-onset Type 1 Diabetes: A Randomized Controlled Trial
    Nwosu, Benjamin Udoka
    Parajuli, Sadichchha
    Jasmin, Gabrielle
    Fleshman, Jody
    Sharma, Rohit B.
    Alonso, Laura C.
    Lee, Austin F.
    Barton, Bruce A.
    JOURNAL OF THE ENDOCRINE SOCIETY, 2022, 6 (01)
  • [2] Effect of Pioglitazone on the Course of New-Onset Type 1 Diabetes Mellitus
    Tafuri, Kimberly Sue
    Godil, Mushtaq Ahmed
    Lane, Andrew Harry
    Wilson, Thomas Allen
    JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY, 2013, 5 (04) : 236 - 239
  • [3] Association between new-onset atrial fibrillation and dementia among individuals with type 2 diabetes
    Zhou, Ying
    Xu, Minzhi
    Yin, Xiaoxv
    Gong, Yanhong
    DIABETES OBESITY & METABOLISM, 2024, 26 (09) : 3715 - 3722
  • [4] Phenotypic Analysis of Human Lymph Nodes in Subjects With New-Onset Type 1 Diabetes and Healthy Individuals by Flow Cytometry
    Yang, Jennie H. M.
    Khatri, Leena
    Mickunas, Marius
    Williams, Evangelia
    Tatovic, Danijela
    Ali, Mohammad Alhadj
    Young, Philippa
    Moyle, Penelope
    Sahni, Vishal
    Wang, Ryan
    Kaur, Rejbinder
    Tannahill, Gillian M.
    Beaton, Andrew R.
    Gerlag, Danielle M.
    Savage, Caroline O. S.
    Rosen, Antonella Napolitano
    Waldron-Lynch, Frank
    Dayan, Colin M.
    Tree, Timothy I. M.
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [5] Tetrahedral Framework Nucleic Acids Reverse New-Onset Type 1 Diabetes
    Gao, Shaojingya
    Zhou, Mi
    Li, Yanjing
    Xiao, Dexuan
    Wang, Yun
    Yao, Yangxue
    Gao, Yang
    Cai, Xiaoxiao
    Lin, Yunfeng
    ACS APPLIED MATERIALS & INTERFACES, 2021, 13 (43) : 50802 - 50811
  • [6] New-Onset Type 1 Diabetes Mellitus After Treatment With Nivolumab for Melanoma
    Baroud, Sarah
    Mirza, Lubna
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (10)
  • [7] A case of polyneuropathy associated with diabetic ketoacidosis in new-onset type 1 diabetes
    Sada, Kokoro
    Hidaka, Shuji
    Takemaru, Makoto
    Ueno, Daisuke
    Shibata, Hirotaka
    JOURNAL OF DIABETES INVESTIGATION, 2022, 13 (05) : 918 - 922
  • [8] Serum irisin levels in new-onset type 2 diabetes
    Choi, Yeon-Kyung
    Kim, Mi-Kyung
    Bae, Kwi Hyun
    Seo, Hyun-Ae
    Jeong, Ji-Yun
    Lee, Won-Kee
    Kim, Jung-Guk
    Lee, In-Kyu
    Park, Keun-Gyu
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2013, 100 (01) : 96 - 101
  • [9] New-onset Type 1 Diabetes after COVID-19 mRNA Vaccination
    Yano, Masahiro
    Morioka, Tomoaki
    Natsuki, Yuka
    Sasaki, Keyaki
    Kakutani, Yoshinori
    Ochi, Akinobu
    Yamazaki, Yuko
    Shoji, Tetsuo
    Emoto, Masanori
    INTERNAL MEDICINE, 2022, 61 (08) : 1197 - 1200
  • [10] The burden of cardiovascular outcomes in heart failure patients with new-onset, prevalent, and without type 2 diabetes
    Zareini, Bochra
    Blanche, Paul
    Holt, Anders
    Malik, Mariam Elmegaard
    Selmer, Christian
    Gislason, Gunnar
    Kristensen, Soren Lund
    Kober, Lars
    Torp-Pedersen, Christian
    Schou, Morten
    Lamberts, Morten
    CLINICAL RESEARCH IN CARDIOLOGY, 2022, 111 (04) : 460 - 468